ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1560

Decreased Level of Peripheral CLA+ Treg Is a Protective Factor of Nervous System Involvement in Behcet’s Syndrome: A Real-World Study in China

Jiachen Li1, Feng Sun2, Wenyan Zhou1 and Tian Liu1, 1Peking University People's Hospital, Beijing, China, 2Peking University People’s Hospital, Beijing, China

Meeting: ACR Convergence 2023

Keywords: Behçet's Syndrome, Treg cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1554–1578) Vasculitis – Non-ANCA-Associated & Related Disorders Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Behcet’s syndrome (BS) is an autoimmune disease characterized by recurrent mucocutaneous ulcerations, vascular and nervous system involvement. While there have been a lot of researches proving that immune cells play a vital role in rheumatic disease, opinions on the effect of different immune cell subsets on BS is inconsistent. Therefore, we performed this real-world study to investigate the changes in the levels of several immune cell subsets in BS, and the correlation between the levels of different immune cell subsets and clinical features in patients with BS.

Methods: This is a retrospective, single-center study conducted in Beijing. We enrolled a total of 136 patients diagnosed with BS in rheumatology and immunology department of Peking University People’s Hospital from 2018 to 2021 and 114 healthy controls (HCs) in this study. All patients met the International Criteria for Behcet’s Disease (ICBD). The levels of peripheral immune cells, including CD4+ T lymphocytes, CD8+ T lymphocytes, B lymphocytes, NK lymphocytes, several subsets of CD4+ T lymphocytes and several subsets of Treg cells were analyzed by flow cytometry. Wilcoxon rank test, student’s t-test and Logistic regression analysis were used and a P-value < 0.05 was considered statistically significant.

Results: Compared with HCs, the absolutely numbers of CD4+ T lymphocytes, B lymphocytes and NK lymphocytes were decreased in BS patients. Among CD4+ T lymphocytes, the proportion of IFN-g, IL-2 and IL-4 producing lymphocytes, follicular helper T cells and Foxp3+ Tregs were significantly elevated, while TNF-a producing lymphocytes, Naïve Th cells and T effectors were significantly decreased in BS patients. (P< 0.05) There was a significant decrease in the absolute number (7.91[ 3.69, 14.92] vs 12.56[ 8.39, 18.15], P< 0.001), proportion of CLA+ Tregs among CD4+ T lymphocytes (1.18[ 0.61, 1.91] vs 1.61[ 1.78, 2.15], P=0.001) and CD4+ regulatory T cells (14.65[ 8.93, 21.63] vs 20.55[ 14.60, 28.43], P< 0.001) in BS patients. We observed that BS patients with arterial aneurysm had lower proportion of CLA+ Treg among Tregs (10.67±5.92 vs 16.90±9.80, P=0.019) compared with those without arterial aneurysm and patients had nervous system involvement had higher proportion of CLA+ Treg among Tregs (20.95[ 16.63,26.85] vs 13.00[ 8.00,20.60], P=0.001) than patients without that manifestation. Multivariate Logistic regression analysis showed that decreased level proportion of CLA+ Treg among Tregs was a protective factor of nervous system involvement in BS patients ( b=0.102, SE=0.037, Wald=7.518, P=0.006, OR=1.107, 95%IC: [ 1.029, 1.190]). The proportion of CLA+ Treg among Tregs in 11 BS patients of 14 was elevated after treatment of corticosteroids and immune suppressor.

Conclusion: BS patients have a decreased level of CLA+ Treg than HCs. Decreased CLA+ Treg may be a protective factor of nervous system involvement in BS patients. BS patients’ level of CLA+ Treg can be elevated after treatment.

Supporting image 1

Comparation of different subsets of immune cells in BS patients and HCs

Supporting image 2

Comparison of CLA+Treg count, proportion of CLA+Treg among CD4+T cells and among Treg cells in BS patients and HCs

Supporting image 3

Multivariate Logistic regression analysis of Neurological subtype Behcet’s syndrome patients


Disclosures: J. Li: None; F. Sun: None; W. Zhou: None; T. Liu: None.

To cite this abstract in AMA style:

Li J, Sun F, Zhou W, Liu T. Decreased Level of Peripheral CLA+ Treg Is a Protective Factor of Nervous System Involvement in Behcet’s Syndrome: A Real-World Study in China [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/decreased-level-of-peripheral-cla-treg-is-a-protective-factor-of-nervous-system-involvement-in-behcets-syndrome-a-real-world-study-in-china/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/decreased-level-of-peripheral-cla-treg-is-a-protective-factor-of-nervous-system-involvement-in-behcets-syndrome-a-real-world-study-in-china/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology